Hepatic lipid profiling of deer mice fed ethanol using 1H and 31P NMR spectroscopy: A dose-dependent subchronic study

Toxicology and Applied Pharmacology

Volumn 264, Issue 3, 2012, Pages 361-369

  Fernando, Harshica ^a   Bhopale, Kamlesh K ^a   Boor, Paul J ^a   Ansari, G A Shakeel ^a   Kaphalia, Bhupendra S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alcohol dehydrogenase; Alcoholic liver disease; Deer mice; Ethanol; Fatty liver; Lipidomics

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID ESTER; PHOSPHOLIPID; PROTON; TRIACYLGLYCEROL;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRY WEIGHT; HISTOLOGY; LIPID ANALYSIS; LIPIDOMICS; MALE; MOUSE; NONHUMAN; PEROMYSCUS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS;

ANIMALS; CHOLESTEROL; CHOLESTEROL ESTERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETHANOL; FATTY ACIDS; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PEROMYSCUS;

PEROMYSCUS; PEROMYSCUS MANICULATUS;

EID: 84867874232     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.07.026     Document Type: Article

References (43)

1. Albano E. New concepts in the pathogenesis of alcoholic liver disease. Expert Rev. Gastroenterol. Hepatol. 2008, 2:749-759.
2. Awl R.A., Frankel E.N., Weisleder D. Synthesis and characterization of triacylglycerols containing linoleate and linolenate. Lipids 1989, 24:866-872.
3. Aydin H.H., Celik H.A., Deveci R., Karacali S., Saydam G., Bedii Omay S., Batur Y. Induction of apoptosis by fatty acid ethyl esters in HepG2 cells. Food Chem. Toxicol. 2005, 43:139-145.
4. Baker H., Luisada-Opper A., Sorrell M.F., Thomson A.D., Frank O. Inhibition by nicotinic acid of hepatic steatosis and alcohol dehydrogenase in ethanol-treated rats. Exp. Mol. Pathol. 1973, 19:106-112.
5. Bhopale K.K., Wu H., Boor P.J., Popov V.L., Ansari G.A., Kaphalia B.S. Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice. Alcohol 2006, 39:179-188.
6. Bhopale K.K., Nauduri D., Soman K.V., Sood G.K., Okorodudu A., Ansari G.A.S., Kaphalia B.S. Differentially altered plasma proteins in patients diagnosed with alcoholic liver disease and nonalcoholic steatohepatitis. Euroasian J. Hepato-Gastroenterology 2011, 1:89-99.
7. Cederbaum A.I. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig. Dis. 2010, 28:802-811.
8. Chapman D., Morrison A. Physical studies of phospholipids. IV. High resolution nuclear magnetic resonance spectra of phospholipids and related substances. J. Biol. Chem. 1966, 241:5044-5052.
9. Ciuclan L., Ehnert S., IIkavets I., et al. TGF-β enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I. J. Hepatol. 2010, 52:407-416.
10. Day C.P., Yeaman S.J. The biochemistry of alcohol-induced fatty liver. Biochem. Biophys. Acta 1994, 1215:33-48.
11. 31P NMR lipidome of ethanol-induced fatty liver. Alcohol. Clin. Exp. Res. 2010, 34:1937-1947.
12. Fernando H., Bhopale K.K., Kondraganti S., Kaphalia B.S., Ansari G.A.S. Lipidomic changes in rat liver after long term exposure to ethanol. Toxicol. Appl. Pharmacol. 2011, 255:127-137.
13. Grunnet N., Kondrup J. The effect of ethanol on the beta-oxidation of fatty acids. Alcohol. Clin. Exp. Res. 1986, 10:64S-68S.
14. de la M Hall P., Lieber C.S., DeCarli L.M., French S.W., Lindros K.O., Jarvelainen H., Bode C., Parlesak A., Bode J.C. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol. Clin. Exp. Res. 2001, 25(5 Suppl.):254S-261S.
15. Ito Y., Abril E.R., Bethea N.W., McCuskey M.K., McCuskey R.S. Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice. Microcirculation 2006, 13:19-27.
16. Kaphalia B.S., Ansari G.A. Fatty acid ethyl esters and ethanol-induced pancreatitis. Cell. Mol. Biol. (Noisy-le-grand) 2001, 47:OL173-179. (Online Pub).
17. Kaphalia B.S., Khan M.F., Carroll R.M., Aronson J., Ansari G.A.S. Subchronic toxicity of 2-chloroethanol and 2-bromoethanol in rats. Res. Commun. Pharmacol. Toxicol. 1996, 1:173-186.
18. Kaphalia B.S., Cai P., Khan M.F., Okorodudu A.O., Ansari G.A. Fatty acid ethyl esters: markers of alcohol abuse and alcoholism. Alcohol 2004, 34:151-158.
19. Kaphalia B.S., Bhopale K.K., Kondragunti S., Wu H., Boor P.J., Ansari G.A.S. Ethanol-induced pancreatic injury and endoplasmic reticulum stress in hepatic alcohol dehydrogenase-deficient deer mice. Toxicol. Appl. Pharmacol. 2010, 246:154-162.
20. Kondraganti S., Bhopale K.K., Ansari G.A.S., Kaphalia B.S. Endoplasmic reticulum stress response in ethanol-induced fatty liver in deer mouse model after subchronic and chronic ethanol exposure. Research Society on Alcoholism's Annual Meeting, Atlanta, June 25-29, 2011 2011.
21. Laposata E.A., Lange L.G. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 1986, 231:497-499.
22. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
23. Lieber C.S., Lefèvre A., Spritz N., Feinman L., DeCarli L.M. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. J. Clin. Invest. 1967, 46:1451-1460.
24. Loftus N., Barnes A., Ashton S., Michopoulos F., Theodoridis G., Wilson I., Ji C., Kaplowitz N. Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis. J. Proteome Res. 2011, 10:705-713.
25. Matyash V., Liebisch G., Kurzchalia T.V., Shevchenko A., Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 2008, 49:1137-1146.
26. Mueller G.C., Fleming M.F., LeMahieu M.A., Lybrand G.S., Barry K.J. Synthesis of phosphatidylethanol-a potential marker for adult males at risk for alcoholism. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9778-9782.
27. NIAAA (National Institute on Alchohol Abuse and Alcoholism) Alcohol Health Services Research. U.S. Department of Health and Human Services, NIH. 10th Special Report to the U.S. Congress on Alcohol and Health 2000.
28. Niemela O., Alatalo P. Biomarkers of alcohol consumption and liver disease. Scand. J. Clin. Lab. Invest. 2010, 70:305-312.
29. Nuutinen H., Lindros K.O., Salaspuro M. Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics. Alcohol. Clin. Exp. Res. 1983, 7:163-168.
30. Palmer K.R., Jenkins W.J. Aldehyde dehydrogenase in alcoholic subjects. Hepatology 1985, 5:260-263.
31. Panes J., Soler X., Pares A., et al. Influence of liver disease on hepatic alcohol and aldehyde dehydrogenases. Gastroenterology 1989, 97:708-714.
32. Panes J., Caballeria J., Guitart R., et al. Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics. Alcohol. Clin. Exp. Res. 1993, 17:48-53.
33. Recknagel R.O., Glende E.A., Dolak J.A., Waller R.L. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 1989, 43:139-154.
34. Ricchi M., Odoardi M.R., Carulli L., et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol. 2009, 24:830-840.
35. Seitz H.K., Salaspuro M., Savolainen M., Haber P., Ishii H., Teschke R., Moshage H., Lieber C.S. From alcohol toxicity to treatment. Alcohol. Clin. Exp. Res. 2005, 29:1341-1350.
36. Sharkawi M. In vivo inhibition of liver alcohol dehydrogenase by ethanol administration. Life Sci. 1984, 35:2353-2357.
37. Shore J.D., Theorell H. Substrate inhibition effects in the liver alcohol dehydrogenase reaction. Arch. Biochem. Biophys. 1966, 117:375-380.
38. Sozio M., Crabb D.W. Alcohol and lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E10-E16.
39. Stewart S.H., Reuben A., Brzezinski W.A., Koch D.G., Basile J., Randall P.K., Miller P.M. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol. 2009, 44:464-467.
40. Sze D.Y., Jardetzky O. Characterization of lipid-composition in stimulated human-lymphocytes by H-1-NMR. Biochim. Biophys. Acta 1990, 1054:198-206.
41. Thomas M., Halsall S., Peters T.J. Role of hepatic acetaldehyde dehydrogenase in alcoholism: demonstration of persistent reduction of cytosolic activity in abstaining patients. Lancet 1982, 2:1057-1058.
42. Wu H., Cai P., Clemens D.L., Jerrells T.R., Ansari G.A., Kaphalia B.S. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism. Toxicol. Appl. Pharmacol. 2006, 216:238-247.
43. Zahlten R.N., Jacobson C.J., Neijtek M.E. Underestimation of alcohol dehydrogenase as a result of various technical pitfalls of the enzyme assay. Biochem. Pharmacol. 1980, 29:1973-1976.